Literature DB >> 8896238

The murine cytomegalovirus immediate-early 1 protein stimulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 promoter.

G Gribaudo1, S Ravaglia, L Guandalini, R Cavallo, M Gariglio, S Landolfo.   

Abstract

The transcription of murine cytomegalovirus (MCMV) immediate-early (IE) genes is regulated by a large and complex enhancer containing several consensus binding sites for the ubiquitous transcription factor NF-kappa B. To verify whether MCMV, like the human CMV, can activate NF-kappa B-dependent transcription, we transfected murine embryo fibroblasts cells with a construct containing three copies of the NF-kappa B element in front of the homologous minimal MCMV IE1-3 promoter. Upon MCMV infection the reporter gene activity was transactivated to about three-fold above the basal level. The specificity of this transactivation was demonstrated by the lack of any significant effect on the activity of DNA constructs containing either a mutated NF-kappa B trimer or an ATF/CRE trimer. Gel shift assays with a NF-kappa B probe revealed that MCMV infection activated DNA binding proteins showing NF-kappa B characteristics. The DNA-binding activity remained elevated during the course of infection and was associated to an increase in the steady-state mRNA levels for the NF-kappa B subunit p105/p50. Since the promoter of the p105/p50 gene was transactivated by MCMV infection during the period in which the IE proteins are expressed, the role of the two major IE transcriptional regulatory proteins was examined. In cotransfection experiments, the IE1 protein transactivated the p105/p50 promoter, whereas the IE3 was ineffective in increasing the transcription of the reporter gene. Taken as a whole, these results demonstrate that MCMV, like its human counterpart, regulates the cellular NF-kappa B activity needed for the initial induction of the IE genes and the progression of the viral replicative cycle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896238     DOI: 10.1016/0168-1702(96)01356-1

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  10 in total

1.  Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts.

Authors:  D Lembo; G Gribaudo; A Hofer; L Riera; M Cornaglia; A Mondo; A Angeretti; M Gariglio; L Thelander; S Landolfo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication.

Authors:  G Gribaudo; L Riera; D Lembo; M De Andrea; M Gariglio; T L Rudge; L F Johnson; S Landolfo
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Selective Inhibition of Murine Cytomegalovirus Viral Gene Expression by the Antiviral Peptide TAT-I24.

Authors:  Hanna Harant
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

4.  Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication.

Authors:  Patrizia Caposio; Michel Dreano; Gianni Garotta; Giorgio Gribaudo; Santo Landolfo
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

5.  Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.

Authors:  Charles H Cook; Yingxue Zhang; Daniel D Sedmak; Larry C Martin; Scott Jewell; Ronald M Ferguson
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

6.  Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro.

Authors:  Chris A Benedict; Ana Angulo; Ginelle Patterson; Sukwon Ha; Huang Huang; Martin Messerle; Carl F Ware; Peter Ghazal
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Temporal profiling of the coding and noncoding murine cytomegalovirus transcriptomes.

Authors:  Paul Lacaze; Thorsten Forster; Alan Ross; Lorraine E Kerr; Eliane Salvo-Chirnside; Vanda Juranic Lisnic; Guillermo H López-Campos; José J García-Ramírez; Martin Messerle; Joanne Trgovcich; Ana Angulo; Peter Ghazal
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

8.  Real-time transcriptional profiling of cellular and viral gene expression during lytic cytomegalovirus infection.

Authors:  Lisa Marcinowski; Michael Lidschreiber; Lukas Windhager; Martina Rieder; Jens B Bosse; Bernd Rädle; Thomas Bonfert; Ildiko Györy; Miranda de Graaf; Olivia Prazeres da Costa; Philip Rosenstiel; Caroline C Friedel; Ralf Zimmer; Zsolt Ruzsics; Lars Dölken
Journal:  PLoS Pathog       Date:  2012-09-06       Impact factor: 6.823

9.  Murine cytomegalovirus immediate-early 1 gene expression correlates with increased GVHD after allogeneic hematopoietic cell transplantation in recipients reactivating from latent infection.

Authors:  Senthilnathan Palaniyandi; Sabarinath Venniyil Radhakrishnan; Fridrik J Karlsson; Karen Y Stokes; Nicolai Kittan; Elisabeth Huber; Gerhard C Hildebrandt
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

10.  Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infection.

Authors:  Sara Rodríguez-Martín; Kai Alexander Kropp; Vanessa Wilhelmi; Vanda Juranic Lisnic; Wei Yuan Hsieh; Mathieu Blanc; Andrew Livingston; Andreas Busche; Hille Tekotte; Martin Messerle; Manfred Auer; Iain Fraser; Stipan Jonjic; Ana Angulo; Matthias J Reddehase; Peter Ghazal
Journal:  PLoS Pathog       Date:  2012-08-30       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.